YWHAE anticorps (AA 1-255)

N° du produit ABIN7142087

Détail du produit anti-YWHAE anticorps

Antigène: YWHAE (14-3-3 epsilon (YWHAE))

Épitope: AA 1-255

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp YWHAE est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain, Souris

Purification: >95%, Protein G purified

Immunogène: Recombinant Human 14-3-3 protein epsilon protein (1-255AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:1000-1:2000, IF:1:200-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur YWHAE

Antigène: YWHAE (14-3-3 epsilon (YWHAE))

Autre désignation: YWHAE (YWHAE Produits)

Synonymes: anticorps 14-3-3, anticorps 14-3-3 epsilon, anticorps 14-3-3-e, anticorps 14-3-3-epsilon, anticorps 14-3-30epsilon, anticorps 14-3-3EPSILON, anticorps 14-3-3e, anticorps 14-3-3omicron, anticorps 1433epsilon, anticorps 143E_DROME, anticorps CG31196, anticorps CT24092, anticorps D14-3-3e, anticorps D14-3-3epsilon, anticorps Dmel\\CG31196, anticorps EK3-5, anticorps PAR-5, anticorps PAR5, anticorps Par-5, anticorps SR3-9, anticorps Su(Raf)3B, anticorps anon-WO0172774.141, anticorps anon-WO02059370.52, anticorps d14-3-3epsilon, anticorps eps, anticorps l(3)j2B10, anticorps par-5, anticorps 14-3-3epsilon, anticorps kcip-1, anticorps mdcr, anticorps mds, anticorps LOC581376, anticorps Ywhae, anticorps ACYPI002517, anticorps YWHAE, anticorps 14-3-3E, anticorps KCIP-1, anticorps MDCR, anticorps MDS, anticorps AU019196, anticorps fe38c12, anticorps wu:fb48f06, anticorps wu:fe38c12, anticorps wu:fi22e10, anticorps ywhae, anticorps zgc:55377, anticorps zgc:77062, anticorps CG31196 gene product from transcript CG31196-RD, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, anticorps 14-3-3 epsilon, anticorps 14-3-3 epsilon protein, anticorps 14-3-3 protein epsilon, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon S homeolog, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1, anticorps 14-3-3epsilon, anticorps ywhae, anticorps LOC581376, anticorps Ywhae, anticorps HCAG_04173, anticorps PTRG_02836, anticorps PTRG_04459, anticorps UREG_07864, anticorps YWHAE, anticorps ywhae.S, anticorps ywhae1

Sujet:

Background: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.

Aliases: 14 3 3 E antibody, 14 3 3 epsilon antibody, 14 3 3E antibody, 14-3-3 protein epsilon antibody, 14-3-3E antibody, 1433E_HUMAN antibody, Epididymis luminal protein 2 antibody, FLJ45465 antibody, FLJ53559 antibody, HEL2 antibody, KCIP 1 antibody, KCIP1 antibody, MDCR antibody, MDS antibody, Mitochondrial import stimulation factor L subunit antibody, Protein kinase C inhibitor protein1 antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon polypeptide antibody, Tyrosine 3/tryptophan 5 monooxygenase activation protein epsilon polypeptide antibody, YWHAE antibody

UniProt: P62258

Pathways: Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, M Phase